Previous Article | Next Article ![]()
Journal of Clinical Microbiology, 03 1997, 548-552, Vol 35, No. 3
A Hobson, A Wald, N Wright and L Corey
Previous studies have shown an association between the approximate titer of
herpes simplex virus (HSV) DNA in clinical specimens and the ability to
isolate HSV from genital secretions. To control for variance in
amplification conditions, we developed a competitive quantitative PCR (QC
PCR) for the detection of HSV DNA. The assay accurately measured from 10 to
10(6) copies of HSV DNA. We compared the QC PCR with our previous
semiquantitative detection method and found concordance for 61 of 63
positive specimens. We also evaluated the HSV DNA content from individual
swabs of genital secretions obtained from individual sites of the genital
tract (cervix, vulva, and rectum) with that from one swab with secretions
from all three sites. The concordance for detecting HSV DNA was 91%; for
only 4 of 143 collection days was there a > 1 log difference between the
two collection methods. A single swab with secretions from all three
genital sites and evaluated in a QC PCR format can accurately measure the
frequency of subclinical and clinical shedding of HSV and the titer of HSV
shed from the genital region. Such an approach should be very useful in the
evaluation of antiviral chemotherapy for HSV.
Copyright © 1997 by the American Society for Microbiology. All rights reserved.
Evaluation of a quantitative competitive PCR assay for measuring herpes simplex virus DNA content in genital tract secretions
Department of Laboratory Medicine, University of Washington, Seattle, USA.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|